Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replacement therapy with hydrocortisone in catecholamine-dependent septic shock.

D Annane1

  • 1Service de Réanimation Médicale, Hôpital Raymond Poincaré, Faculté de Médecine Paris-Ouest, Université Paris V, Garches, France. djillali.annane@rpc.ap-hop-paris.fr

Journal of Endotoxin Research
|November 22, 2001
PubMed
Summary

Corticosteroid therapy, specifically hydrocortisone replacement, shows promise in improving survival rates for patients with septic shock. This approach addresses the hypothalamic-pituitary-adrenal axis response, offering new hope in critical care settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous DNAJB4 deletion revealing myopathy with acute respiratory failure.

Revue neurologique·2025
Same author

Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study.

Revue neurologique·2022
Same author

Perioperative fluid management for major elective surgery.

The British journal of surgery·2020
Same author

Mismatch negativity to predict subsequent awakening in deeply sedated critically ill patients.

British journal of anaesthesia·2018
Same author

Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.

Spinal cord·2016
Same author

Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study.

Spinal cord·2016

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Endocrinology

Background:

  • Septic shock remains a leading cause of intensive care unit mortality worldwide.
  • Despite advances in understanding inflammation, survival rates have not significantly improved.
  • Previous trials of high-dose corticosteroids showed no benefit in septic shock.

Purpose of the Study:

  • To re-evaluate the role of corticosteroids in septic shock management.
  • To assess the efficacy of hydrocortisone replacement therapy in severe sepsis.
  • To investigate the impact of hypothalamic-pituitary-adrenal axis integrity on septic shock outcomes.

Main Methods:

  • Review of recent randomized controlled trials on corticosteroid therapy in severe sepsis.
  • Evaluation of hydrocortisone replacement therapy as a treatment strategy.

Related Experiment Videos

  • Analysis of data focusing on morbidity and survival rates in septic shock patients.

    • Main Results:

    • Hydrocortisone replacement therapy in severe sepsis suggests a reduction in morbidity.
    • This therapeutic approach may positively influence survival rates from septic shock.
    • Recent findings emphasize the importance of the hypothalamic-pituitary-adrenal axis in sepsis response.

    Conclusions:

    • Hydrocortisone replacement therapy is a promising strategy for managing septic shock.
    • This approach may improve patient outcomes and survival in severe sepsis.
    • Further research into corticosteroid efficacy in septic shock is warranted.